@prefix chebi: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix species: . @prefix occursIn: . @prefix obo: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:1784; a RNA: . sub:_2 occursIn: obo:CLO_0003665, species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:46742; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"Nutlin 3\") -> r(HGNC:CDKN1A)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "Dissociation of p73 and HDM2 leads to increased p73 transcriptional activity with upregulation of p73 target genes noxa, puma and p21 (RT-PCR and Western Blot) Noxa, puma and p21waf1/cip1 mRNA levels increased by 2.5-, 2.3- and 3.2- fold, respectively, following Nutlin-3 treatment (Figures 3a and b and Supplementary Figure S1"; prov:wasQuotedFrom pubmed:17700533 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17700533; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:12.239+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }